Short Interest in Advanced Biomed Inc. (NASDAQ:ADVB) Drops By 72.3%

Advanced Biomed Inc. (NASDAQ:ADVB) saw a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 3,722 shares, a decrease of 72.3% from the April 30th total of 13,424 shares. Based on an average daily volume of 522,925 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.4% of the shares of the company are sold short.

Advanced Biomed Stock Up 0.8%

Shares of NASDAQ:ADVB opened at $3.91 on Friday. The firm has a market capitalization of $5.40 million, a P/E ratio of 0.81 and a beta of 0.56. Advanced Biomed has a 1 year low of $3.61 and a 1 year high of $24.00. The business’s 50 day moving average is $5.04.

Advanced Biomed (NASDAQ:ADVB) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.38) earnings per share (EPS) for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings downgraded Advanced Biomed from a “sell (d)” rating to a “sell (d-)” rating in a research report on Tuesday. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.